USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
U.S. Neuropathic Pain Medications Markets
U.S. Neuropathic Pain Medications Markets
RELEASE DATE
26-Aug-2004
26-Aug-2004
REGION
North America
North America
Research Code: A842-01-00-00-00
SKU: HC00978-NA-MR_04854
$2,450.00
Special Price $1,837.50 save 25 %
In stock
SKU
HC00978-NA-MR_04854
Description
This research service highlights the emerging opportunities in the U.S. neuropathic pain medications market and analyzes the current and future competitive landscape. Included in this research service are revenue forecasts, market shares, patient forecasts, market and technology trends, factors affecting market growth, major issues and challenges, pricing trends, and product analysis. The market is segmented by product class - opioids, antidepressants, topical analgesics, anticonvulsants and emerging therapies. Also included are individual revenue and patient forecasts for major products such as Neurontin, pregabalin, generic gabapentin, and ruboxistaurin.
Table of Contents
Executive Summary
- Executive Summary
Overview
- Scope and Segmentation
- Research Methodology
- Introduction
- Market and Technology Trends
Neuropathic Pain Syndromes
- Diabetic Neuropathy
- Postherpetic Neuralgia
- HIV Neuropathy
- Trigeminal Neuralgia
Treatment Options
- Diabetic Neuropathic Pain
- Postherpetic Neuralgia
- HIV-associated Neuropathic Pain
- Trigeminal Neuralgia
Market Dynamics
- Demand Analysis
- Patient Forecasts
- Revenue Forecasts
- Factors Affecting Market Growth
- Industry Issues and Challenges
Competitive Landscape
- Competitive Structure
- Pipeline Analysis
- Market Share Analysis
Frost & Sullivan Awards
- Company of the Year Award
- Technology Innovation Award
- Product Differentiation Leadership Award
- Industry Innovation and Advancement of the Year Award
Segment Highlights
Overview
Market Forecasts and Trends
Competitive Analysis
Segment Highlights
Overview
Market Forecasts and Trends
Competitive Analysis
Segment Highlights
Overview
Market Forecasts and Trends
Competitive Analysis
Segment Highlights
Overview
Market Forecasts and Trends
Competitive Analysis
Segment Highlights
Overview
Market Forecasts and Trends
Decision Support Database
Popular Topics
This research service highlights the emerging opportunities in the U.S. neuropathic pain medications market and analyzes the current and future competitive landscape. Included in this research service are revenue forecasts, market shares, patient forecasts, market and technology trends, factors affecting market growth, major issues and challenges, pricing trends, and product analysis. The market is segmented by product class - opioids, antidepressants, topical analgesics, anticonvulsants and emerging therapies. Also included are individual revenue and patient forecasts for major products such as Neurontin, pregabalin, generic gabapentin, and ruboxistaurin.
| No Index | No |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | A842-01-00-00-00 |
| Is Prebook | No |